Quinoline compounds decrease in vitro spontaneous proliferation of peripheral blood mononuclear cells (PBMC) from human T-cell lymphotropic virus (HTLV) type-1-infected patients - 20/08/08
Corresponding author. Tel.: +33 (0)1 46 83 55 94; fax: +33 (0)1 46 83 53 99.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 6 |
| Iconographies | 3 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
In vitro spontaneous proliferation is the immunological hallmark of peripheral blood mononuclear cells (PBMC) from HTLV-1-infected individuals. Quinoline compounds down regulate in vitro cell proliferation of HTLV-1 transformed cell lines. In the present study we assessed the capacity of quinolines to inhibit spontaneous cell proliferation of PBMC from HTLV-1-infected individuals. Twenty-two quinolines were evaluated. Toxicity was first assessed on PBMC from healthy donors by using both the Trypan blue technique and Tetrazolium Salt (XTT) method and then the antiproliferative effect was measured by a classic lymphoproliferative assay on PBMC from three HTLV-1-infected individuals, in the presence of decreasing concentrations of quinolines (from 100μM to 0.8μM), after 5 days of culture.
We found that 14 out of 22 compounds were non-toxic to PBMC from uninfected individuals at 100, 50 and 10μM. Four compounds presented a capacity to inhibit more than 80% of the spontaneous proliferation: 7 at 25μM and 10, 20 and 23 at 100μM. Our results indicate that some quinolines block spontaneous proliferation of PBMC from HTLV-1-infected individuals.
Le texte complet de cet article est disponible en PDF.Keywords : HTLV-1, 2-substituted quinolines, Antiviral, PBMC
Plan
Vol 62 - N° 7
P. 430-435 - septembre 2008 Retour au numéro
Article précédent
- New cyclin-dependant kinase inhibitors as potential anti-tumor agents
- Hervé Galons, Laurent Meijer, Nassima Oumata, Karima Bettayeb
- Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts
- Giordano Stabellini, Chiara Balducci, Cinzia Lilli, Lorella Marinucci, Ennio Becchetti, Francesco Carinci, Carla Calastrini, Claudia Dolci, Eleonora Lumare, Paola Locci
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?